Overview
The continuing expansion of disclosure requirements in the US and EU leave many sponsors and academia considering disclosure strategy, developing operational measures, and looking for efficient ways to manage dissemination of clinical trial protocol information and results data. The users of clinical trial information is varied which provides both opportunities and challenges for how the information is provided.
Featured
Want to learn more about Clinical Trial Disclosure & Data Transparency Conference? You've come to the right site!
Program Committee
-
Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States -
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark -
Gerard Lynch Associate Director, Clinical Operations
Biogen, United Kingdom -
Matthias Zerm, PhD Lead Expert, Clinical Trial Disclosure and R&D Processes
Germany
Have an account?